Effects of exenatide (exendin-4) on glycemic control over 30 weeksin sulfonylurea-treated patients with type 2 diabetes. Diabetes Care27:2628–2635 26.Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG2005 Exenatide versus insulin glargine in patients with subop- timally controlled type 2 diabetes: a randomized trial. Ann InternMed 143:559–569 27.Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fine- man MS, Baron AD 2005 Effects of exenatide (exendin-4) on gly- cemic control over 30 weeks in patients with type 2 diabetes treatedwith metformin and a sulfonylurea. Diabetes Care 28:1083–1091 28.DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD 2005 Effects of exenatide (exendin-4) on glycemic control andweight over 30 weeks in metformin-treated patients with type 2diabetes. Diabetes Care 28:1092–1100 29.Bjerre Knudsen L, Madsen LW, Andersen S, Almholt K, de Boer AS,